Spire Healthcare and falling house prices: Markets live
Spire Healthcare (SPI) agreed to a £1.03bn takeover by a consortium, with a 66% premium. Shareholders representing 53% support the deal. Team Internet (TIG) reported higher net debt and lower cash conversion. Ferrexpo (FXPO) shares rose 37% after restarting production in Ukraine. Ashmore (ASHM) reported a 7% revenue decline but 17% profit increase. UK house prices fell 0.4% in August. SigmaRoc (SRC) reported 14% profit growth and a new acquisition. IQE (IQE) plans to move from AIM to the main ma
How this was made

The 30-second read
Why it matters
The Spire deal dominates market reaction, while other firms report earnings, leverage changes, and strategic moves.
Market read
Primary M&A news with secondary earnings and operational updates across UK mid‑caps.
What to watch
Geopolitical risk to Ferrexpo's Ukrainian operations may limit upside despite fundraise.
Background
The article bundles several company updates, with Spire Healthcare's takeover as the headline event.
Ticker impact
Ares Management is part of the consortium acquiring Spire Healthcare.
minor impact; focus on deal execution rather than price move
Ares is a private‑equity investor; the transaction size is material but not directly reflected in its stock.
Market effects
Healthcare M&A activity may spur further consolidation; UK mid‑cap sector sees heightened interest.
UK market gains from Spire deal; Ukrainian mining recovery supports commodity exposure.
Large‑scale cross‑border M&A highlights private‑equity appetite for European assets.
Counterpoint
Deal premium may be overvalued; post‑deal integration risk could depress SPI.L.
Key entities
- CompanySpire Healthcare
UK private‑healthcare provider being acquired.
- Investment FirmToscafund
Lead bidder in the Spire takeover.
- CompanyFerrexpo
Ukrainian iron‑ore pellet producer restarting production.


